Incyte
INCY
496 hedge funds and large institutions have $22.6B invested in Incyte in 2017 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 193 increasing their positions, 192 reducing their positions, and 43 closing their positions.
23% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 43
1% more funds holding
Funds holding: 493 → 496 (+3)
1% more repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 192
0.56% less ownership
Funds ownership: 92.52% → 91.95% (-0.56%)
5% less capital invested
Capital invested by funds: $23.9B → $22.6B (-$1.25B)
22% less funds holding in top 10
Funds holding in top 10: 18 → 14 (-4)
28% less call options, than puts
Call options by funds: $227M | Put options by funds: $317M
Top Buyers
Top Sellers
INCY Hedge Fund Activity: Q3 2017 in Review
496 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q3 2017, worth a combined $22.6B — down 5.2% from $23.9B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new INCY positions and 43 closed out — a net gain of 10 holders — while 193 added to existing stakes and 192 trimmed.
The largest buyer was Manning & Napier Advisors, opening a new position worth an estimated $136M. The largest seller was T. Rowe Price Associates, cutting an estimated $72.3M.
- 496 institutional investors held Incyte (INCY) as of Q3 2017, up from 493 in Q2 2017.
- Funds reported $22.6B of Incyte stock for Q3 2017, down 5.2% quarter-over-quarter.
- 53 funds opened new Incyte positions in Q3 2017 and 43 closed out, a net change of +10 holders.
- The largest Incyte buyer in Q3 2017 was Manning & Napier Advisors, an estimated $136M added.
- The largest Incyte seller in Q3 2017 was T. Rowe Price Associates, an estimated $72.3M sold.
Based on aggregated 13F filings for Q3 2017.